---
figid: PMC6599319__12885_2019_5833_Fig1_HTML
figlink: /pmc/articles/PMC6599319/figure/Fig1/
number: F1
caption: Simplified schematic illustration of pathways for Wnt/β-catenin, ERK/MAPK
  and PI3K/Akt and PGE2-metabolism. A) Canonical Wnt/β-catenin signaling. The engagement
  of the Wnt receptor, Frizzled, leads to the inhibition of the β-catenin destruction
  complex, composed of APC, axin and GSK3β. β-catenin thereby avoids ubiquitination
  and subsequent degradation, thus allowing it to translocate to the nucleus to activate
  an array of regulatory genes. B) The RAS/RAF/MEK/ERK MAPK pathway. Stimulation of
  the receptor tyrosine kinase (RTK) or G-protein coupled receptors (GPCRs) leads
  to sequential activation of RAS, RAF, MEK, and ERK causing modification of substrates
  promoting cell survival and proliferation. C) In the PI3K/Akt pathway, activation
  of the RTK or GPCRs leads to sequential modification of phosphatidyl inositol residues
  of the phospholipid bilayer. In this process, PI3K generates PIP3. PIP3 in association
  with PDK1 activates Akt. Akt then modulates the activity of downstream substrates
  including mTOR, thus promoting proliferation and cell survival. D) PGE2-metabolism.
  PGE2-synthesis begins with catalytic hydrolysis of membrane phospholipids by cytoplasmic
  phospholipase A2 (cPLA2), thus releasing arachidonic acid (AA). By the action of
  the COX-1 and COX-2, AA is converted to prostaglandin H2 (PGH2). PGH2 is then converted
  to PGE2 by prostaglandin E synthase (PTGES). The main exporter of PGE2 is thought
  to be multi-drug resistance related polypeptide 4 (MRP4). Removal of PGE2 from the
  extracellular compartment around target cells occurs by diffusion to the blood stream
  and subsequent uptake and degradation in lung, liver or kidney endothelial cells
  or by import to colonic epithelial cells through the prostaglandin transporter (PGT)
  and subsequent degradation by 15-prostaglandin dehydrogenase (15-PGDH). Through
  autocrine and paracrine signaling, extracellular PGE2 stimulates the prostaglandin
  receptors EP1–4. The EPs are GPCRs with EP1 being Gαq-coupled while EP2 and EP4
  are Gαs-coupled. EP3 is capable of coupling with different G-proteins including
  Gαi, Gαs and Gαq
pmcid: PMC6599319
papertitle: Possible predisposition for colorectal carcinogenesis due to altered gene
  expressions in normal appearing mucosa from patients with colorectal neoplasia.
reftext: Christian Hunnicke Petersen, et al. BMC Cancer. 2019;19:643.
pmc_ranked_result_index: '138374'
pathway_score: 0.9640651
filename: 12885_2019_5833_Fig1_HTML.jpg
figtitle: Simplified schematic illustration of pathways for Wnt/Beta-catenin, ERK/MAPK
  and PI3K/Akt and PGE2-metabolism
year: '2019'
organisms:
- Homo sapiens
ndex: 5b61e964-debd-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6599319__12885_2019_5833_Fig1_HTML.html
  '@type': Dataset
  description: Simplified schematic illustration of pathways for Wnt/β-catenin, ERK/MAPK
    and PI3K/Akt and PGE2-metabolism. A) Canonical Wnt/β-catenin signaling. The engagement
    of the Wnt receptor, Frizzled, leads to the inhibition of the β-catenin destruction
    complex, composed of APC, axin and GSK3β. β-catenin thereby avoids ubiquitination
    and subsequent degradation, thus allowing it to translocate to the nucleus to
    activate an array of regulatory genes. B) The RAS/RAF/MEK/ERK MAPK pathway. Stimulation
    of the receptor tyrosine kinase (RTK) or G-protein coupled receptors (GPCRs) leads
    to sequential activation of RAS, RAF, MEK, and ERK causing modification of substrates
    promoting cell survival and proliferation. C) In the PI3K/Akt pathway, activation
    of the RTK or GPCRs leads to sequential modification of phosphatidyl inositol
    residues of the phospholipid bilayer. In this process, PI3K generates PIP3. PIP3
    in association with PDK1 activates Akt. Akt then modulates the activity of downstream
    substrates including mTOR, thus promoting proliferation and cell survival. D)
    PGE2-metabolism. PGE2-synthesis begins with catalytic hydrolysis of membrane phospholipids
    by cytoplasmic phospholipase A2 (cPLA2), thus releasing arachidonic acid (AA).
    By the action of the COX-1 and COX-2, AA is converted to prostaglandin H2 (PGH2).
    PGH2 is then converted to PGE2 by prostaglandin E synthase (PTGES). The main exporter
    of PGE2 is thought to be multi-drug resistance related polypeptide 4 (MRP4). Removal
    of PGE2 from the extracellular compartment around target cells occurs by diffusion
    to the blood stream and subsequent uptake and degradation in lung, liver or kidney
    endothelial cells or by import to colonic epithelial cells through the prostaglandin
    transporter (PGT) and subsequent degradation by 15-prostaglandin dehydrogenase
    (15-PGDH). Through autocrine and paracrine signaling, extracellular PGE2 stimulates
    the prostaglandin receptors EP1–4. The EPs are GPCRs with EP1 being Gαq-coupled
    while EP2 and EP4 are Gαs-coupled. EP3 is capable of coupling with different G-proteins
    including Gαi, Gαs and Gαq
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GSK3B
  - ABCC4
  - PDK1
  - GNAQ
  - GAST
  - MAP2K1
  - MAP2K2
  - WNT7A
  - WNT7B
  - WNT5A
  - WNT6
  - WNT10B
  - WNT11
  - WNT8A
  - WNT8B
  - FZD9
  - WNT2
  - WNT3
  - WNT5B
  - WNT3A
  - FZD10
  - FZD2
  - FZD5
  - FZD3
  - FZD1
  - FZD4
  - FZD6
  - FZD8
  - WNT4
  - WNT1
  - AKT3
  - AKT1
  - AKT2
  - APC
  - AXIN1
  - AXIN2
  - KAT5
  - SLCO2A1
  - PTGES
  - ARAF
  - FZD7
  - C1QA
  - C2
  - PTGER1
  - PTGER4
  - MAPK1
  - MAPK3
  - C1QC
  - C1R
  - C1S
  - C1QB
  - BRAF
  - HRAS
  - KRAS
  - RAF1
  - WNT16
  - WNT10A
  - WNT2B
  - NRAS
  - WNT9B
  - WNT9A
  - PGE2
  - Aracidonic
  - PGE
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: MRP4
  symbol: MRP4
  source: hgnc_alias_symbol
  hgnc_symbol: ABCC4
  entrez: '10257'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: Gaq
  symbol: G-ALPHA-q
  source: hgnc_alias_symbol
  hgnc_symbol: GNAQ
  entrez: '2776'
- word: Gas
  symbol: GAS
  source: hgnc_prev_symbol
  hgnc_symbol: GAST
  entrez: '2520'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: AXIN
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: AXIN
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: CPLA2
  symbol: cPLA2
  source: hgnc_alias_symbol
  hgnc_symbol: KAT5
  entrez: '10524'
- word: PGT
  symbol: PGT
  source: hgnc_alias_symbol
  hgnc_symbol: SLCO2A1
  entrez: '6578'
- word: PTGES
  symbol: PTGES
  source: hgnc_symbol
  hgnc_symbol: PTGES
  entrez: '9536'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Cох-1
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1QA
  entrez: '712'
- word: cох-2
  symbol: C2
  source: hgnc_symbol
  hgnc_symbol: C2
  entrez: '717'
- word: EP1
  symbol: EP1
  source: hgnc_alias_symbol
  hgnc_symbol: PTGER1
  entrez: '5731'
- word: EP4
  symbol: EP4
  source: hgnc_alias_symbol
  hgnc_symbol: PTGER4
  entrez: '5734'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Cох-1
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1QC
  entrez: '714'
- word: Cох-1
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1R
  entrez: '715'
- word: Cох-1
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1S
  entrez: '716'
- word: Cох-1
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1QB
  entrez: '713'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
chemicals:
- word: PGE2
  source: MESH
  identifier: D015232
- word: Aracidonic
  source: ''
  identifier: ''
- word: PGE
  source: MESH
  identifier: D011458
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC6599319__F1
redirect_from: /figures/PMC6599319__F1
figtype: Figure
---
